Hirotaka Hoshi Medical-Industrial Translational Research Center Fukushima Medical University Biography Publications Institution JoVE Articles Hirotaka Hoshi has not added a biography. If you are Hirotaka Hoshi and would like to personalize this page please email our Author Liaison for assistance. Publications Construction of Patient-derived Tumor Models to Evaluate Anticancer Agents and Cancer Immunotherapy Oncology Letters. May, 2021 | Pubmed ID: 33841567 An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids Cells. 05, 2019 | Pubmed ID: 31137590 Evaluation of Anticancer Agents Using Patient-derived Tumor Organoids Characteristically Similar to Source Tissues Oncology Reports. Aug, 2018 | Pubmed ID: 29917168 Evaluation System for Arrhythmogenic Potential of Drugs Using Human-induced Pluripotent Stem Cell-derived Cardiomyocytes and Gene Expression Analysis The Journal of Toxicological Sciences. 2017 | Pubmed ID: 29142174 Construction of a Novel Cell-based Assay for the Evaluation of Anti-EGFR Drug Efficacy Against EGFR Mutation Oncology Reports. Jan, 2017 | Pubmed ID: 27840973 High-Throughput In Vitro Assay met behulp van patiënt-afgeleide tumor organoïden Arisa Higa1, Nobuhiko Takahashi2,3, Gen Hiyama2, Hirosumi Tamura2, Hirotaka Hoshi2, Kenju Shimomura3, Shinya Watanabe2, Motoki Takagi2 1FUJIFILM Wako Bio Solutions Corporation, 2Medical-Industrial Translational Research Center, Fukushima Medical University, 3Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University JoVE 62668 Cancer Research
High-Throughput In Vitro Assay met behulp van patiënt-afgeleide tumor organoïden Arisa Higa1, Nobuhiko Takahashi2,3, Gen Hiyama2, Hirosumi Tamura2, Hirotaka Hoshi2, Kenju Shimomura3, Shinya Watanabe2, Motoki Takagi2 1FUJIFILM Wako Bio Solutions Corporation, 2Medical-Industrial Translational Research Center, Fukushima Medical University, 3Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University JoVE 62668 Cancer Research
